Related Experiment Video

Updated: Jun 1, 2026

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
09:35

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

Admission hyperglycemia is a reliable outcome predictor in children with severe traumatic brain injury

Nazik Aşılıoğlu1, Fatih Turna, Muhammet Sükrü Paksu

  • 1Division of Pediatric Critical Care, School of Medicine, Ondokuz Mayıs University, Samsun, Turkey. nazika@omu.edu.tr

Jornal De Pediatria
|May 21, 2011
PubMed

Insights

Admission hyperglycemia in children with severe brain injury is linked to worse outcomes and higher mortality. High blood glucose on admission may indicate extensive brain damage and poorer prognosis.

Area of Science:

  • Pediatric Critical Care Medicine
  • Neurotrauma Research
  • Metabolic Disorders in Critical Illness

Background:

  • Severe brain injury in children presents significant management challenges.
  • Understanding factors influencing outcomes is crucial for improving patient care.

Purpose of the Study:

  • To investigate the association between admission hyperglycemia and outcomes in pediatric severe brain injury patients.
  • To evaluate this relationship at hospital discharge and 6 months post-discharge.

Main Methods:

  • Retrospective analysis of blood glucose levels in 61 pediatric patients with severe brain injury.
  • Hyperglycemia defined as blood glucose > 150 mg/dL.
  • Outcomes assessed using the Glasgow Outcome Scale and mortality at discharge and 6 months.

Main Results:

  • 83.6% of patients had admission hyperglycemia (mean glucose 251 mg/dL).
  • Higher admission glucose correlated with head trauma severity (r=0.46).
  • Non-survivors and patients with poor outcomes had significantly higher admission glucose levels.

Conclusions:

  • Admission hyperglycemia may serve as a marker for extensive brain damage in pediatric severe brain injury.
  • Hyperglycemia on admission is associated with increased mortality and adverse outcomes.
  • Further research is warranted on the impact of glycemic control on outcomes.
Abstract

More Related Videos

Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury09:58

Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury

Published on: November 9, 2018

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Traumatic Brain Injury l: Introduction01:28

Traumatic Brain Injury l: Introduction

DefinitionTraumatic brain injury, or TBI, is a disturbance of normal brain function induced by an external mechanical force, such as a direct blow to the head or a penetrating injury. It can affect both brain structure and function, producing a wide range of clinical outcomes. TBI is a heterogeneous condition, meaning its effects may differ based on the type, location, and severity of the injury.Basis of ClassificationTBI is classified based on severity, injury mechanism, or pathophysiology. In...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...